Cardiogenic shock due to citomegalovirus myocarditis: successful clinical treatment

Detalhes bibliográficos
Autor(a) principal: Baumgratz,José Francisco
Data de Publicação: 2010
Outros Autores: Vila,José Henrique Andrade, Silva,José Pedro da, Fonseca,Luciana da, Rodrigues,Edwal A. Campos, Knobel,Elias
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Cardiovascular Surgery (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382010000200004
Resumo: OBJECTIVE: Cytomegalovirus (CMV) systemic disease and myocarditis in healthy persons is infrequently reported in the literature, although in increasing numbers in recent years. The importance of the recognition of the syndrome that usually has an initial picture of a mononucleosis like infection in an otherwise healthy person, is the available therapeutic agent, ganciclovir, that can cure the infectious disease. METHODS: We analyzed the clinical result of pulsotherapy with steroids in a patient with CMV myocarditis after 7 days of etiological treatment, with ganciclovir, intravenous vasodilators, and the conventional treatment for congestive heart failure. RESULTS: The clinical condition of the patient improved accordingly to the better function of the left ventricle, and the ganciclovir was kept for 21 days, most of it in an out patient basis. The patient was dismissed from the hospital, with normal myocardial function. CONCLUSION: Potentially curable forms of myocarditis, like M pneumoniae and CMV, for example, can have an initial disproportionate aggression to the myocardium, by the acute inflammatory reaction, that can by itself make worse the damage to the LV function. In our opinion, the blockade of this process by pulsotherapy with steroids can help in the treatment of these patients. We understand that the different scenario of immunosuppressive treatments for the possible auto immunity of the more chronic forms of the presumably post viral cardiomyopathy has been in dispute in the literature, and has stolen the focus from the truly acute cases.
id SBCCV-1_993e3eeb01bb0143eb231b38615fad38
oai_identifier_str oai:scielo:S0102-76382010000200004
network_acronym_str SBCCV-1
network_name_str Brazilian Journal of Cardiovascular Surgery (Online)
repository_id_str
spelling Cardiogenic shock due to citomegalovirus myocarditis: successful clinical treatmentMyocarditisCardiogenic shockGanciclovirPulse therapy, drugOBJECTIVE: Cytomegalovirus (CMV) systemic disease and myocarditis in healthy persons is infrequently reported in the literature, although in increasing numbers in recent years. The importance of the recognition of the syndrome that usually has an initial picture of a mononucleosis like infection in an otherwise healthy person, is the available therapeutic agent, ganciclovir, that can cure the infectious disease. METHODS: We analyzed the clinical result of pulsotherapy with steroids in a patient with CMV myocarditis after 7 days of etiological treatment, with ganciclovir, intravenous vasodilators, and the conventional treatment for congestive heart failure. RESULTS: The clinical condition of the patient improved accordingly to the better function of the left ventricle, and the ganciclovir was kept for 21 days, most of it in an out patient basis. The patient was dismissed from the hospital, with normal myocardial function. CONCLUSION: Potentially curable forms of myocarditis, like M pneumoniae and CMV, for example, can have an initial disproportionate aggression to the myocardium, by the acute inflammatory reaction, that can by itself make worse the damage to the LV function. In our opinion, the blockade of this process by pulsotherapy with steroids can help in the treatment of these patients. We understand that the different scenario of immunosuppressive treatments for the possible auto immunity of the more chronic forms of the presumably post viral cardiomyopathy has been in dispute in the literature, and has stolen the focus from the truly acute cases.Sociedade Brasileira de Cirurgia Cardiovascular2010-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382010000200004Brazilian Journal of Cardiovascular Surgery v.25 n.2 2010reponame:Brazilian Journal of Cardiovascular Surgery (Online)instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)instacron:SBCCV10.1590/S0102-76382010000200004info:eu-repo/semantics/openAccessBaumgratz,José FranciscoVila,José Henrique AndradeSilva,José Pedro daFonseca,Luciana daRodrigues,Edwal A. CamposKnobel,Eliaseng2010-08-23T00:00:00Zoai:scielo:S0102-76382010000200004Revistahttp://www.rbccv.org.br/https://old.scielo.br/oai/scielo-oai.php||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br1678-97410102-7638opendoar:2010-08-23T00:00Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)false
dc.title.none.fl_str_mv Cardiogenic shock due to citomegalovirus myocarditis: successful clinical treatment
title Cardiogenic shock due to citomegalovirus myocarditis: successful clinical treatment
spellingShingle Cardiogenic shock due to citomegalovirus myocarditis: successful clinical treatment
Baumgratz,José Francisco
Myocarditis
Cardiogenic shock
Ganciclovir
Pulse therapy, drug
title_short Cardiogenic shock due to citomegalovirus myocarditis: successful clinical treatment
title_full Cardiogenic shock due to citomegalovirus myocarditis: successful clinical treatment
title_fullStr Cardiogenic shock due to citomegalovirus myocarditis: successful clinical treatment
title_full_unstemmed Cardiogenic shock due to citomegalovirus myocarditis: successful clinical treatment
title_sort Cardiogenic shock due to citomegalovirus myocarditis: successful clinical treatment
author Baumgratz,José Francisco
author_facet Baumgratz,José Francisco
Vila,José Henrique Andrade
Silva,José Pedro da
Fonseca,Luciana da
Rodrigues,Edwal A. Campos
Knobel,Elias
author_role author
author2 Vila,José Henrique Andrade
Silva,José Pedro da
Fonseca,Luciana da
Rodrigues,Edwal A. Campos
Knobel,Elias
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Baumgratz,José Francisco
Vila,José Henrique Andrade
Silva,José Pedro da
Fonseca,Luciana da
Rodrigues,Edwal A. Campos
Knobel,Elias
dc.subject.por.fl_str_mv Myocarditis
Cardiogenic shock
Ganciclovir
Pulse therapy, drug
topic Myocarditis
Cardiogenic shock
Ganciclovir
Pulse therapy, drug
description OBJECTIVE: Cytomegalovirus (CMV) systemic disease and myocarditis in healthy persons is infrequently reported in the literature, although in increasing numbers in recent years. The importance of the recognition of the syndrome that usually has an initial picture of a mononucleosis like infection in an otherwise healthy person, is the available therapeutic agent, ganciclovir, that can cure the infectious disease. METHODS: We analyzed the clinical result of pulsotherapy with steroids in a patient with CMV myocarditis after 7 days of etiological treatment, with ganciclovir, intravenous vasodilators, and the conventional treatment for congestive heart failure. RESULTS: The clinical condition of the patient improved accordingly to the better function of the left ventricle, and the ganciclovir was kept for 21 days, most of it in an out patient basis. The patient was dismissed from the hospital, with normal myocardial function. CONCLUSION: Potentially curable forms of myocarditis, like M pneumoniae and CMV, for example, can have an initial disproportionate aggression to the myocardium, by the acute inflammatory reaction, that can by itself make worse the damage to the LV function. In our opinion, the blockade of this process by pulsotherapy with steroids can help in the treatment of these patients. We understand that the different scenario of immunosuppressive treatments for the possible auto immunity of the more chronic forms of the presumably post viral cardiomyopathy has been in dispute in the literature, and has stolen the focus from the truly acute cases.
publishDate 2010
dc.date.none.fl_str_mv 2010-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382010000200004
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382010000200004
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0102-76382010000200004
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Cirurgia Cardiovascular
publisher.none.fl_str_mv Sociedade Brasileira de Cirurgia Cardiovascular
dc.source.none.fl_str_mv Brazilian Journal of Cardiovascular Surgery v.25 n.2 2010
reponame:Brazilian Journal of Cardiovascular Surgery (Online)
instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
instacron:SBCCV
instname_str Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
instacron_str SBCCV
institution SBCCV
reponame_str Brazilian Journal of Cardiovascular Surgery (Online)
collection Brazilian Journal of Cardiovascular Surgery (Online)
repository.name.fl_str_mv Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
repository.mail.fl_str_mv ||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br
_version_ 1752126597128781824